
JOINN Biologics: Premier CDMO provider for biotech & pharmaceuticals, offering end-to-end development and manufacturing services.
Founded in the California Bay Area, JOINN Biologics is dedicated to advancing biotechnology and biopharmaceuticals through its premier contract development and manufacturing organization (CDMO) services. The company’s core mission is to support drug discovery and development by providing a comprehensive range of services from early-stage development to clinical manufacturing. JOINN Biologics focuses on biologics and advanced therapies, catering to biotech and pharmaceutical companies on a global scale.
Notable for its affiliation with the JOINN Family, which boasts over 20 years of success in drug discovery and development, JOINN Biologics has established itself as a key player in the industry. The company has achieved significant milestones in supporting numerous biotech and pharmaceutical projects, contributing to the advancement of innovative therapies. With a strong track record and a commitment to excellence, JOINN Biologics continues to make a substantial impact on the global healthcare landscape.

Societal Cdmo
societalcdmo.com

NJ Bio
njbio.com

August Bioservices
augustbio.com

JK BioPharma Solutions

WuXi Biologics
wuxibiologics.com

Rjs Biologics

BridGene Biosciences

Center for Breakthrough Medicines

Great Lakes Biologics

Amador Bioscience

Curie.Bio
curie.bio

Conjupro Biotherapeutics

Lucaspye BIO
lucaspyebio.com

Pharmaceutics International

Goodwin Biotechnology
Companies similar to Joinn Biologics include Societal Cdmo, NJ Bio, August Bioservices and JK BioPharma Solutions.
Joinn Biologics was founded in 2018.
Joinn Biologics' headquarters is located in Richmond, CA, US.
Joinn Biologics' most recent funding round was for $150M (USD) in August 2021.
As of Aug 1, 2021, Joinn Biologics has raised a total of $210M (USD).
Joinn Biologics has 375 employees as of Feb 4, 2024.